Comparing the price and salary of Maunjaro with the Wegobi

The price of Maunjaro has dropped to below 300,000 won, competing with Wegobi.

 

The biggest topic of conversation in the domestic obesity treatment market recently is the price of Maunjaro.
This is because the price of its existing competing drug, Wigobi, was significantly reduced when Eli Lilly's obesity and diabetes treatment Maunzaro was launched.

In fact, at the Jongno 5-ga pharmacy, the price of Wegobi has fallen below 240,000 won, and the price of Maunjaro has also fallen below 300,000 won, forming a full-scale price competition structure.

 

 

Launch of Maunjaro and price reduction of Wegobi

 

When news of the domestic launch of Maunja spread, Wegobi lowered the supply price by 10-40% depending on the capacity.
As a result, the 0.25 mg Wegobi product can be purchased at pharmacies for around 230,000 won.
High-capacity products have also had their prices adjusted to a maximum of 390,000 won.

 

In line with this, Maunjaro The domestic release price also dropped to as low as 290,000 won.
The two major obesity treatment drugs are locked in fierce competition.

 

Monthly price and capacity by Maunjaro

 

The monthly price for a mount is formed as follows:

 

- 2.5mg: Lowest price: approximately 290,000 won, average price: approximately 320,000 won
- 5mg: Lowest price: approximately 380,000 won, average price: approximately 410,000 won

 

 

That is, the price of Maunjaro is higher than the previous estimate of 174,000 won, but
Due to market competition, the price is already stabilizing, falling below 300,000 won.

 

Compare prices of Wegobi Maunjaro

 

As of now, the prices of the Wegobi Maunja are as follows.

 

- Wegobi 0.25mg: Approximately 230,000 won
- Wegobi 0.5mg: Approximately 250,000 won
- Wegobi 1.0mg: Approximately 270,000 won
- Wegobi 2.4mg: Approximately 390,000 won

 

- Maunjaro 2.5mg: Starting at 290,000 won
- 5mg of Maunjaro: approximately 380,000 won

 

Although there are price differences depending on capacity,
The Wigobi is cheaper in low-capacity terms, and the Maunjaro is competitive in mid-capacity terms.

 

 

Is it possible to apply the salary to the mount?

 

What many patients are looking forward to is The salary is applied based on the number of employees.

Currently, it is difficult to apply insurance in Korea for the sole purpose of obesity treatment.
It appears that limited coverage may be possible in cases where there are clear indications, such as in patients with diabetes.

 

If the salary is applied, the monthly price of the mount will drop significantly and the burden on the patient will be reduced.
There is also the possibility of misuse and abuse, so a cautious approach is necessary.

 

Domestic obesity treatment market expansion prospects

 

According to global healthcare organization IQVIA,
The domestic obesity treatment market grew from KRW 134 billion in 2019 to KRW 178 billion in 2023.
After the launch of Wegobi in 2024, the market size grew to 270 billion won.

This launch and price competition in Maunjaro is reducing the burden on patients, attracting more consumers to the market.
Just as the botulinum toxin market in the past experienced explosive growth as prices dropped with the introduction of domestic products,
The obesity treatment market is also likely to expand into lifestyle consumer goods as price barriers are lowered.

 

 

Conclusion: Price is more important than future prospects

 

To sum up,

- The current price of Maunjaro is at least 290,000 won.
- Consumer burden eased through price competition with Wegobi Maunja
- Monthly prices for Mounter vary greatly depending on capacity and may vary depending on insurance coverage.
- When applying for a salary as a lump sum, certain individuals, such as diabetic patients, may benefit.

 

After 2026, a full-scale price reduction competition will begin.
In addition to weight loss effectiveness, price competitiveness, ease of administration, and tolerability will be key factors in consumer selection.

 

So now, we should not just look at the domestic release price as a mount,
It is necessary to monitor insurance coverage and market changes together.

 

 

 

See more related articles!

➡️A comprehensive review of how to use the Maunjaro, and check out the changes since its domestic release

➡️Maunjaro Domestic Launch Salary Summary | Check Release Date and Insurance Benefits